Pharma Serialization Growth Expands Foil Specification
Pharmaceutical producers increasingly specify legibility-tested, smear-resistant coding tape previously limited to simple wax-grade use, applying it across an expanding list of serialization and track-and-trace formats as regulation increasingly makes print-contrast a measurable compliance consideration rather than a manageable consumables detail. This shift is creating substantial new demand beyond the category's traditional wax base, giving legibility-capable manufacturers a genuine growth avenue tied to pharmaceutical expansion rather than pure food-packaging volume growth. Manufacturers with established production-line relationships are capturing disproportionate share of this expanding demand across newly converted accounts worldwide. That pattern shows few signs of slowing down across major accounts today.
Market Impact: Sustains 22% of wax-grade volume








